Presenter/Author Information
Michael Williams PharmD, BCOP , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health Follow Erin Franzen PharmD, BCOP , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health Follow Shanze Arshad , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health / University of Kentucky College of Medicine Brittany Mejaki PharmD, BCOP , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health Follow Syed N. Haider MD , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health Follow Syed A. Abutalib MD , Transplant and Cellular Therapy, Aurora St. Luke's Medical Center, Advocate Health Follow Sherjeel Sana MD , Transplant and Cellular Therapy, Advocate Lutheran General Hospital, Advocate Health Follow Stephen Medlin DO , Transplant and Cellular Therapy, Inova Schar Cancer Institute Follow Zartash Gul MD , Transplant and Cellular Therapy, Inova Schar Cancer Institute Follow
Recommended Citation
Williams M, Franzen E, Arshad S, et al. Toxicity and Outcomes Associated With Reduced-Dose Post-Transplant Cyclophosphamide. Presented at Scientific Day; May 21, 2025; Park Ridge, IL.
Presentation Notes
Presented at Scientific Day; May 21, 2025; Park Ridge, IL.
Full Text of Presentation
wf_yes
Document Type
Oral/Podium Presentation
Since May 15, 2025
COinS
May 21st, 3:02 PM
May 21st, 3:07 PM
Toxicity and Outcomes Associated With Reduced-Dose Post-Transplant Cyclophosphamide
To view the content in your browser, please download Adobe Reader or, alternately, Download the file to your hard drive.
NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.
Affiliations
Aurora St. Luke's Medical Center, Advocate Lutheran General Hospital